Biofunctionalized magnetic nanoparticles for specifically detecting biomarkers of Alzheimer's disease in vitro

ACS Chemical Neuroscience

Volumn 2, Issue 9, 2011, Pages 500-505

  Yang, Che Chuan ^a   Yang, Shieh Yueh ^a,b   Chieh, Jen Jie ^a   Horng, Herng Er ^a   Hong, Chin Yih ^c   Yang, Hong Chang ^d   Chen, K H ^a   Shih, B Y ^a   Chen, Ta Fu ^e   Chiu, Ming Jang ^d,e  

^a NATIONAL TAIWAN NORMAL UNIVERSITY   (Taiwan)

^b MAGQU CO LTD   (Taiwan)

^c NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Immunomagnetic reduction; Magnetic nanoparticles; amyloid

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; MAGNETIC NANOPARTICLE; WATER; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA-PROTEIN (1-42); ANTIBODY; BIOLOGICAL MARKER; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; NANOPARTICLE; PEPTIDE FRAGMENT;

ALZHEIMER DISEASE; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; EARLY DIAGNOSIS; HUMAN; IMMUNOASSAY; IMMUNOLOGICAL PROCEDURES; IMMUNOMAGNETIC REDUCTION; IN VITRO STUDY; LIMIT OF DETECTION; MAGNETISM; MOLECULAR STABILITY; PARTICLE SIZE; PHYSICAL PARAMETERS; PLASMA; SYNTHESIS; ALGORITHM; CHEMISTRY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOCHEMISTRY; IMMUNOLOGY; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING;

ALGORITHMS; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANTIBODIES; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOCHEMISTRY; INDICATORS AND REAGENTS; MAGNETIC RESONANCE IMAGING; MAGNETICS; NANOPARTICLES; PARTICLE SIZE; PEPTIDE FRAGMENTS;

EID: 84865491507     PISSN: None     EISSN: 19487193     Source Type: Journal    
DOI: 10.1021/cn200028j     Document Type: Article

References (23)

1. Roberts, D., Zhu, W. L., Frommen, C. M., and Rosenzweig, Z. (2000) Synthesis of gadolinium oxide magnetoliposomes for magnetic resonance imaging. J. Appl. Phys. 87, 6208.
2. Wu, C. C., Lin, L. Y., Lin, L. C., Huang, H. C., Liu, Y. B., Tsai, M. C., Gao, Y. L., Wang, W. C., Yang, S. Y., Horng, H. E., Yang, H. C., Tseng, W. K., Lee, T. L., Hsuan, C. F., and Tseng, I. W. Y. (2008) Biofunctionalized magnetic nanoparticles for in vitro labeling and in vivo locating specific biomolecules. Appl. Phys. Lett. 92, 142504.
3. Inglis, D. W., Riehn, R., Sturm, J. C., and Austin, R. H. (2006) Microfluidic high gradientmagnetic cell separation. J. Appl. Phys. 99, 08K101.
4. Kötitz, R., Weitschies, W., Trahms, L., Brewer, W., and Semmler, W. J. (1999) Determination of the binding reaction between avidin and biotin by relaxation measurements of magnetic nanoparticles. J. Magn. Magn. Mater. 194, 62.
5. Horng, H. E., Yang, S. Y., Huang, Y. W., Jiang, W. Q., Hong, C. Y., and Yang, H. C. (2005) Nanomagnetic particles for SQUID-based magnetically labeled immunoassay. IEEE Trans. Appl. Supercond. 15, 668.
6. Yang, H. C., Yang, S. Y., Liao, S. H., Fang, G. L., Huang, W. H., Liu, C. H., Horng, H. E., and Hong, C. Y. (2006) Magnetic relaxation measurement in immunoassay using high-transition-temperature superconducting quantum interference device system. J. Appl. Phys. 99, 124701.
7. Krause, H. J., Wolters, N., Zhang, Y., Offenhäusser, A., Miethe, P., Meyer, M. H. F., Hartmann, M., and Keusgen, M. (2007) Magnetic particle detection by frequency mixing for immunoassay applications. J. Magn. Magn. Mater. 311, 436.
8. csuperconducting quantum interference device magnetometer. Jpn. J. Appl. Phys. 42, L1436.
9. Tapiola, T., Alafuzoff, I., Herukka, S. K., Parkkinen, L., Hartikainen, P., Soininen, H., and Pirttilä, T. (2009) Cerebrospinal fluid β-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Arch. Neurol. 66, 382.
10. Sobow, T., Flirski, M., Liberski, P. P., and Kloszewska, I. (2007) Plasma Aβ levels as predictors of response to rivastigmine treatment in Alzheimer's disease. Acta Neurobiol. Exp. 67, 131.
11. Fagan, A. M., Roe, C. M., Xiong, C., Mintun, M. A., Morris, J. C., and Holtzman, D. M. (2007) Cerebrospinal fluid tau/β-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults. Arch. Neurol. 64, 343.
12. Frankfort, S. V., Tulner, L. R., van Campen, J. P., Verbeek, M. M., Jansen, R. W., and Beijnen, J. H. (2008) Amyloid β protein and tau in cerebrospinal fluid and plasma as biomarkers for dementia: a review of recent literature. Curr. Clin. Pharmacol. 3, 123.
13. Blennow, K., Hampel, H., Weiner, M., and Zetterberg, H. (2010) Is it time for biomarker-based diagnostic criteria for prodromal Alzheimer's disease? Nat. Rev. Neurol. 6, 131.
14. Skaat, H., Sorci, M., Belfort, G, and Margel, S. (2008) Effect of maghemite nanoparticles on insulin amyloid fibril formation: Selective labeling, kinetics, and fibril removal by a magnetic field. J. Biomed. Mater. Res., Part A 91, 342.
15. Skaat, H., and Margel, S. (2009) Synthesis of fluorescentmaghemite nanoparticles as multimodal imaging agents for amyloidbeta fibrils detection and removal by a magnetic field. Biochem. Biophys. Res. Commun. 386, 645.
16. Humpel, C. (2010) Identifying and validating biomarkers for Alzheimer's disease. Trends Biotechnol. 29, 26.
17. Zetterberg, H., and Blennow, K. (2006) Plasma Aβ in Alzheimer's disease-up or down? Lancet Neurol. 5, 638.
18. Cedazo-Mnguez, A., and Winblad, B. (2010) Biomarkers for Alzheimer's disease and other forms of dementia: clinical needs, limitations and future aspects. Exp. Gerontol. 45, 5.
19. Zetterberg, H., Blennow, K., and Hanse, E. (2010) Amyloid β and APP as biomarkers for Alzheimer's disease. Exp. Gerontol. 45, 23.
20. Irizarry, M. C. (2004) Biomarkers of Alzheimer disease in plasma. NeuroRx 1, 226.
21. Jiang, W., Yang, H. C., Yang, S. Y., Horng, H. E., Hung, J. C., Chen, Y. C., and Hong, C. Y. (2004) Preparation and properties of superparamagnetic nanoparticles with narrow size distribution and biocompatible. J. Magn. Magn. Mater. 283, 210.
22. Yang, S. Y., Jian, Z. F., Horng, H. E., Hong, C. Y., Yang, H. C., Wu, C. C., and Lee, Y. H. (2008) Dual immobilization and magnetic manipulation of magnetic nanoparticles. J. Magn. Magn. Mater. 320, 2688.
23. csuperconducting quantum interference devices. J. Appl. Phys. 103, 14703.